Jundishapur Journal of Microbiology

Published by: Kowsar

Evaluation of Hepatitis B Surface Antibody and Specific Gamma Interferon Response in Health Care Workers After Vaccination

Mohammad Hosein Sarmast Shooshtari 1 , 2 , Manoochehr Makvandi 1 , 3 , 4 , Mojtaba Rasti 3 , * , Niloofar Neisi 1 , 3 , Nasrin Rastegarvand 3 , Amir Pouremamali 3 , Mehrdad Sadeghi Haj 3 and Fardin Ghaedi 5
Authors Information
1 Research Institute for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of General Surgery, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Virology Department, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 Health Research Institute, Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Deputy of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: January 2015, 8 (1); e59742
  • Published Online: December 6, 2014
  • Article Type: Research Article
  • Received: July 25, 2013
  • Revised: September 24, 2013
  • Accepted: October 6, 2013
  • DOI: 10.5812/jjm.13801

To Cite: Sarmast Shooshtari M H, Makvandi M, Rasti M, Neisi N, Rastegarvand N, et al. Evaluation of Hepatitis B Surface Antibody and Specific Gamma Interferon Response in Health Care Workers After Vaccination, Jundishapur J Microbiol. 2015 ; 8(1):e59742. doi: 10.5812/jjm.13801.

Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Mizukoshi E, Sidney J, Livingston B, Ghany M, Hoofnagle JH, Sette A, et al. Cellular immune responses to the hepatitis B virus polymerase. J Immunol. 2004; 173(9): 5863-71[PubMed]
  • 2. Alavian SM, Mahboobi N, Mahboobi N. Anti-HBs antibody status and some of its associated factors in dental health care workers in Tehran University of Medical Sciences: Anti-HBs Ab and associated factors in dental society. Hepat Mon. 2011; 11(2): 99-102[PubMed]
  • 3. Di Giuseppe G, Nobile CG, Marinelli P, Angelillo IF. A survey of knowledge, attitudes, and behavior of Italian dentists toward immunization. Vaccine. 2007; 25(9): 1669-75[DOI][PubMed]
  • 4. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med. 1997; 157(22): 2601-5[PubMed]
  • 5. Wang J, Gujar SA, Cova L, Michalak TI. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity. J Virol. 2007; 81(2): 903-16[DOI][PubMed]
  • 6. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 1996; 4(1): 25-36[PubMed]
  • 7. Mancini-Bourgine M, Fontaine H, Brechot C, Pol S, Michel ML. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine. 2006; 24(21): 4482-9[DOI][PubMed]
  • 8. Mast E, Mahoney F, Kane M, Margolis H. Vaccines. 2004; : 299 –337
  • 9. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med. 2004; 351(27): 2832-8[DOI][PubMed]
  • 10. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991; 40: 1-25[PubMed]
  • 11. Poland GA. Hepatitis B immunization in health care workers. Dealing with vaccine nonresponse. Am J Prev Med. 1998; 15(1): 73-7[PubMed]
  • 12. Sjogren MH. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination. Am J Med. 2005; 118 Suppl 10A: 34S-9S[DOI][PubMed]
  • 13. Hamidi B, Bahadori M, Mansouri S, Nategh R. Seroepidemiological survey of hepatitis B markers in National Iranian Oil Company (NIOC) health workers in Tehran prior to mass vaccination. Arch Irn Med. 2000; 3: 1-5
  • 14. Jafarzadeh A, Montazerifar SJ. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. J Ayub Med Coll Abbottabad. 2006; 18(4): 4-9[PubMed]
  • 15. Jafarzadeh A, Zarei S, Shokri F. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates. Vaccine. 2008; 26(2): 269-76[DOI][PubMed]
  • 16. Alavian SM, Mansouri S, Abouzari M, Assari S, Bonab MS, Miri SM. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005). Eur J Gastroenterol Hepatol. 2008; 20(2): 131-4[DOI][PubMed]
  • 17. Bahmani MK, Khosravi A, Mobasser A, Ghezelsofla E. Seroprevalence of hepatitis B virus infection and vaccination compliance among health care workers in Fars Province, Iran. Arch Clin Infect Dis. 2010; 5(1): 45-50
  • 18. Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis. 2008; 197(10): 1419-26[DOI][PubMed]
  • 19. Saberifiroozi M, Gholamzadeh S, Serati AR. The long-term immunity among health care workers vaccinated against hepatitis B virus in a large referral hospital in southern Iran. Arch Iran Med. 2006; 9(3): 204-7[PubMed]
  • 20. Bertoletti A, Tan AT, Gehring AJ. HBV-Specific Adaptive Immunity. Viruses. 2009; 1(2): 91-103[DOI][PubMed]
  • 21. Dimitropoulou D, Karakantza M, Theodorou GL, Leonidou L, Assimakopoulos SF, Mouzaki A, et al. Serum cytokine profile in patients with hepatitis B e antigen-negative chronic active hepatitis B and inactive hepatitis B virus carriers. World J Gastrointest Pathophysiol. 2013; 4(1): 24-7[DOI][PubMed]
  • 22. Kardar GA, Jeddi-Tehrani M, Shokri F. Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine. Scand J Immunol. 2002; 55(3): 311-4[PubMed]
  • 23. Jafarzadeh A, Shokri F. TH1 and TH2 responses are influenced by HLA antigens in healthy neonates vaccinated with recombinant hepatitis B vaccine. Iran J Allergy Asthma Immunol. 2012; 11(4): 308-15[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments